Skip Main Navigation
Page Content

Horizon Discovery is a UK Biotechnology company that combines deep scientific experience in translational research with a precision gene-editing platform incorporating rAAV, CRISPR and ZFN technologies.  The company provides custom cell line and in vivo model generation services for research and bioproduction applications, molecular reference standards, in vivo disease models, and contract research and screening services to over 1,000 organisations engaged in research; drug discovery and development; clinical diagnostics; and biopharmaceutical process optimization.  Horizon aspires to provide science-driven research solutions that lead to better understanding of the genetic basis of disease and better outcomes for patients, from sequence to treatment.

Save This Event

Event Saved